FDA Approves Label Change for Alzheimer’s Drug

Brain edema risk expected to be less with new donanemab dosing schedule

The real question is whether it works?

https://cnmri.com/2025/07/14/fda-approves-label-change-for-alzheimers-drug/

#alzheimers #dementia #kisunla #donanemab #fda #brainedema